ŞAHİN, T. K. Et Al. 2020. Anti-prostate cancer activity of a nanoformulation of the spleen tyrosine kinase (SYK) inhibitor C61. ANTI-CANCER DRUGS , vol.31, no.6 , 609-616.

ŞAHİN, T. K., AKTEPE, O. H., Uckun, F. M., & YALÇIN, Ş., (2020). Anti-prostate cancer activity of a nanoformulation of the spleen tyrosine kinase (SYK) inhibitor C61. ANTI-CANCER DRUGS , vol.31, no.6, 609-616.

ŞAHİN, TAHA Et Al. "Anti-prostate cancer activity of a nanoformulation of the spleen tyrosine kinase (SYK) inhibitor C61," ANTI-CANCER DRUGS , vol.31, no.6, 609-616, 2020

ŞAHİN, TAHA K. Et Al. "Anti-prostate cancer activity of a nanoformulation of the spleen tyrosine kinase (SYK) inhibitor C61." ANTI-CANCER DRUGS , vol.31, no.6, pp.609-616, 2020

ŞAHİN, T. K. Et Al. (2020) . "Anti-prostate cancer activity of a nanoformulation of the spleen tyrosine kinase (SYK) inhibitor C61." ANTI-CANCER DRUGS , vol.31, no.6, pp.609-616.

@article{article, author={TAHA KORAY ŞAHİN Et Al. }, title={Anti-prostate cancer activity of a nanoformulation of the spleen tyrosine kinase (SYK) inhibitor C61}, journal={ANTI-CANCER DRUGS}, year=2020, pages={609-616} }